Pediatrics Doctors in New London, NH Accepting Medicare

5 Pediatrics doctors found. Showing 1 - 5

Dr. Gina Apicelli Schwartz, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 273 County Rd, New London, NH 03257 Phone: 603-526-2911

Dr. James Mcguire, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 273 County Road, New London, NH 03257 Phone: 603-526-2911    Fax: 603-526-5085

Sarah Lester, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 273 County Road, New London, NH 03257 Phone: 603-526-2911    Fax: 603-526-5085

Anna Maria Konopka, MD Pediatrics - Adolescent Medicine Medicare: Not Enrolled in Medicare Practice Location: 92 Bunker Rd, New London, NH 03257 Phone: 603-526-6029    Fax: 603-526-6029

Lauren Anne Geddes Wirth, MD Pediatrics - Adolescent Medicine Medicare: Medicare Enrolled Practice Location: 273 County Rd, New London, NH 03257 Phone: 603-526-2911

News Archive

VDF announces launch of new PAD exercise training toolkit for health professionals

The Vascular Disease Foundation announced the launch of its new "Peripheral Arterial Disease Exercise Training Toolkit: A Guide for Health Care Professionals." This toolkit was developed jointly by the Vascular Disease Foundation and the American Association of Cardiovascular and Pulmonary Rehabilitation and may be accessed online at www.vdf.org/rehab-toolkit/index.php

Dick Cheney's heart transplant success at 71

Former vice president Dick Cheney, at 71, who has survived five heart attacks and years of heart failure, is recuperating in intensive care at a Northern Virginia hospital after undergoing a heart transplant Saturday. He had been on the waiting list for 20 months.

Research reveals key protein structure, paves way for better anti-anxiety drugs

When new medicines are invented, the drug may hit the intended target and nullify the symptoms, but nailing a bull's eye - one that produces zero side effects - can be quite elusive.

Results of PCF funded study could impact the standard of care for prostate cancer patients

Twice-yearly intravenous infusion with denosumab, a new targeted therapy to stop bone loss, increased bone density and prevented spinal fractures in men receiving androgen-deprivation therapy for prostate cancer. The report from an international research study, the first to document reduced fracture risk in men receiving the hormone-blocking treatment, was published today in the print edition of the New England Journal of Medicine (NEJM). Both fundamental research on rank ligand (RANKL) in prostate cancer bone metastasis and other molecular factors involved in the denosumab study were supported at Massachusetts General Hospital with funding from the Prostate Cancer Foundation (PCF).

FDA issues update on smoking cessation products

If you want to quit smoking, you'll need willpower - and perhaps the aid of a product that's intended to help you beat the addiction.

Read more Medical News

› Verified 9 days ago